Name: Spero Therapeutics, Inc. (SPRO) Balance Sheet
Creator: FinSpry

Spero Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Spero Therapeutics, Inc. (SPRO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	52.89	76.33	109.11	112.58	85.21	82.05	115.44
Short-Term Investments	0.00	0.00	0.00	33.82	41.70	0.00	0.00
Cash & Short-Term Investments	52.89	76.33	109.11	146.40	126.91	82.05	115.44
Accounts Receivable	52.48	50.70	1.08	2.64	6.18	7.76	1.30
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.91	4.18	3.38	8.83	6.06	0.79	0.00
Total Current Assets	107.28	131.21	113.57	157.87	139.15	95.41	124.22
Non-Current Assets
Property, Plant & Equipment (Net)	3.11	4.16	5.49	7.56	8.78	7.15	2.89
Other Non-Current Assets	0.15	0.44	5.74	5.64	5.52	3.52	1.66
Total Non-Current Assets	3.27	51.18	11.23	13.20	15.15	10.69	4.79
Total Assets	110.54	182.39	124.80	171.07	153.45	106.10	129.01
Current Liabilities
Accounts Payable	7.31	1.38	0.62	1.10	1.16	4.15	11.87
Short-Term Debt	1.75	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	17.72	6.56	8.97	14.35	12.24	0.00	0.00
Deferred Revenue	22.12	27.11	10.37	1.86	0.00	0.00	0.00
Other Current Liabilities	0.46	6.56	0.45	0.00	12.24	21.59	0.22
Total Current Liabilities	49.07	37.15	21.65	18.67	14.34	26.66	12.32
Non-Current Liabilities
Long-Term Debt	2.55	3.83	4.96	48.41	7.07	4.87	0.00
Other Non-Current Liabilities	0.58	0.09	0.10	0.94	0.18	0.00	0.00
Total Non-Current Liabilities	15.35	38.34	27.22	64.11	7.07	4.87	0.83
Total Liabilities	64.42	75.50	48.87	82.78	21.41	31.53	13.15
Stockholders' Equity
Common Stock	0.06	0.05	0.05	0.03	0.03	0.00	0.00
Retained Earnings	-459.64	-391.07	-413.88	-367.46	-277.71	-199.43	-138.50
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	-0.01	0.02	-0.03
Additional Paid-in Capital	505.71	497.91	489.76	455.72	409.72	273.97	254.01
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.36
Shares Outstanding	54.59	53.00	52.46	32.39	0.00	0.00	0.00
Total Stockholders' Equity	46.12	106.89	75.93	88.29	132.04	74.57	115.86
Total Liabilities & Equity	110.54	182.39	124.80	171.07	153.45	106.10	129.01